Atovaquone-proguanil resistance in imported falciparum malaria in a young child

被引:13
作者
Rose, Gregory W. [1 ]
Suh, Kathryn N. [1 ]
Kain, Kevin C. [2 ]
Le Saux, Nicole [3 ]
McCarthy, Anne E. [1 ]
机构
[1] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada
[2] Univ Toronto, Toronto Gen Hosp, McLaughlin Rotman Ctr Global Hlth, Trop Dis Unit, Toronto, ON M5G 1L7, Canada
[3] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada
关键词
plasmodium falciparum; resistance; cytochrome b; atovaquone-proguanil; malarone;
D O I
10.1097/INF.0b013e318167918d
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We discuss a case of atovaquone-proguanil treatment failure in a child from Mozambique, recently arrived in North America. Four weeks after completing therapy, symptomatic parasitemia recurred, caused by Plasmodium falciparum parasites bearing a Tyr268Ser mutation in cytochrome b. We review the literature concerning atovaquone-proguanil resistance, and emphasize the importance of follow-up and consideration of resistance where patients have relapsed symptoms.
引用
收藏
页码:567 / 569
页数:3
相关论文
共 13 条
[1]   Atovaquone/proguanil resistance in Africa: a case report [J].
David, KP ;
Alifrangis, M ;
Salanti, A ;
Vestergaard, LS ;
Ronn, A ;
Bygbjerg, I .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (11-12) :897-898
[2]   Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride:: case reports [J].
Färnert, A ;
Lindberg, J ;
Gil, P ;
Swedberg, G ;
Berqvist, Y ;
Thapar, MM ;
Lindegårdh, N ;
Berezcky, S ;
Björkman, A .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7390) :628-629
[3]  
Fivelman Quinton L, 2002, Malar J, V1, P1
[4]   Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north american traveller to west Africa [J].
Kuhn, S ;
Gill, MJ ;
Kain, KC .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (04) :407-409
[5]   First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America [J].
Legrand, Eric ;
Demar, Magalie ;
Volney, Beatrice ;
Ekala, Marie-Therese ;
Quinternet, Marc ;
Bouchier, Christiane ;
Fandeur, Thierry ;
Rogier, Christophe ;
Carme, Bernard ;
Puijalon, Odile Mercereau ;
Esterre, Philippe .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2280-2281
[6]   Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand [J].
Looareesuwan, S ;
Viravan, C ;
Webster, HK ;
Kyle, DE ;
Canfield, CJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 54 (01) :62-66
[7]   Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers [J].
Musset, L ;
Pradines, B ;
Parzy, D ;
Durand, R ;
Bigot, P ;
Le Bras, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (01) :110-115
[8]   Parallel evolution of adaptive mutations in plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment [J].
Musset, Lise ;
Le Bras, Jacques ;
Clain, Jerome .
MOLECULAR BIOLOGY AND EVOLUTION, 2007, 24 (08) :1582-1585
[9]   Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations [J].
Musset, Lise ;
Bouchaud, Olivier ;
Matheron, Sophie ;
Massias, Laurent ;
Le Bras, Jacques .
MICROBES AND INFECTION, 2006, 8 (11) :2599-2604
[10]   Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa [J].
Schwartz, E ;
Bujanover, S ;
Kain, KC .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) :450-451